Geode Capital Management »

Indaptus Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Indaptus Therapeutics (INDP) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Indaptus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Indaptus Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indaptus Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $49k 27k 1.82

More positions owned by Geode Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Meta Platforms Inc-class A Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Visa Inc-class A Shares Com Cl A (V)

View all positions for Geode Capital Management

Top funds holding Indaptus Therapeutics

Citadel Advisors
Geode Capital Management
Tower Research Capital
Morgan Stanley
SBI Securities

View all funds holding Indaptus Therapeutics